Benjamin Hanfstein
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 27
- Chronic Myeloid Leukemia Treatments 22
- Acute Myeloid Leukemia Research 5
- Genetics 18
- Chronic Lymphocytic Leukemia Research 18
- Co-authors
- Andreas Hochhaus (23 shared papers)Rüdiger Hehlmann (11 shared papers)Sebastian Kreil (2 shared papers)Paul La Rosée (4 shared papers)Ute Berger (1 shared paper)Claudia Schoch (1 shared paper)A. Corbin (1 shared paper)Harald Gschaidmeier (1 shared paper)
- Journals
- Blood (10 papers)Leukemia (4 papers)Leukemia Research (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Haematologica (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Benjamin Hanfstein
29 papers receiving 1.1k citations
Benjamin Hanfstein's Hit Papers
Peers
Comparison fields: 5 of 48
- Hematology 1.0k
- Genetics 692
- Rheumatology 486
- Oncology 132
- Pathology and Forensic Medicine 73
Countries citing papers authored by Benjamin Hanfstein
This map shows the geographic impact of Benjamin Hanfstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Hanfstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Hanfstein more than expected).
Fields of papers citing papers by Benjamin Hanfstein
This network shows the impact of papers produced by Benjamin Hanfstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Hanfstein. The network helps show where Benjamin Hanfstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Hanfstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy Hit paper breakdown → | 2002 | 720 |
| 2 | 2009 | 145 | |
| 3 | 2008 | 43 | |
| 4 | 2010 | 39 | |
| 5 | 2010 | 36 | |
| 6 | 2009 | 30 | |
| 7 | 2014 | 25 | |
| 8 | 2015 | 19 | |
| 9 | 2003 | 16 | |
| 10 | 2014 | 16 | |
| 11 | 2008 | 12 | |
| 12 | 2012 | 10 | |
| 13 | 2010 | 9 | |
| 14 | 2007 | 8 | |
| 15 | 2014 | 8 | |
| 16 | 2015 | 6 | |
| 17 | 2012 | 6 | |
| 18 | 2009 | 5 | |
| 19 | 2010 | 5 | |
| 20 | 2011 | 5 |
About Benjamin Hanfstein
Benjamin Hanfstein is a scholar working on Hematology, Genetics, Rheumatology, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (18 papers), Eosinophilic Disorders and Syndromes (12 papers), Acute Myeloid Leukemia Research (5 papers), Retinoids in leukemia and cellular processes (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Lymphoma Diagnosis and Treatment (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Hematology (1.0k citations), Genetics (692 citations), Rheumatology (486 citations), Oncology (132 citations) and Pathology and Forensic Medicine (73 citations). Benjamin Hanfstein has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Andreas Hochhaus, Rüdiger Hehlmann, Sebastian Kreil, Paul La Rosée, Ute Berger, Claudia Schoch, A. Corbin, Harald Gschaidmeier, Tanja Lahaye and Brian Druker. Their work appears in journals such as Blood, Leukemia, Leukemia Research, Journal of Cancer Research and Clinical Oncology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.